Abstract
(2011). Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis. Journal of Medical Economics: Vol. 14, No. 2, pp. 207-216. doi: 10.3111/13696998.2011.561390

This publication has 33 references indexed in Scilit: